Cargando…

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma

PURPOSE: The aim of this study was to define somatostatin (SST) and somatostatin receptor type 1 (SSTR1) methylation profiles for head and neck squamous cell carcinoma (HNSCC) tumors at diagnosis and follow up and to evaluate their prognostic significance and value as a biomarker. METHODS: Gene expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misawa, Kiyoshi, Misawa, Yuki, Kondo, Haruki, Mochizuki, Daiki, Imai, Atsushi, Fukushima, Hirofumi, Uehara, Takayuki, Kanazawa, Takeharu, Mineta, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348545/ https://www.ncbi.nlm.nih.gov/pubmed/25734919 http://dx.doi.org/10.1371/journal.pone.0118588

Ejemplares similares

Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis
por: Kanazawa, Takeharu, et al.
Publicado: (2018)

Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Primary combined small and squamous cell carcinoma of the hypopharynx: A case report
por: MISAWA, KIYOSHI, et al.
Publicado: (2016)

Telomere shortening in head and neck cancer: association between DNA demethylation and survival
por: Yamada, Satoshi, et al.
Publicado: (2021)

Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Late recurrence of breast carcinoma metastasis to the hypopharynx: a case report
por: Izumi, Chisako, et al.
Publicado: (2016)

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

5-Hydroxymethylcytosine and ten-eleven translocation dioxygenases in head and neck carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
por: Liguz-Lecznar, Monika, et al.
Publicado: (2022)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Somatostatin and Somatostatin-Containing Neurons in Shaping Neuronal Activity and Plasticity
por: Liguz-Lecznar, Monika, et al.
Publicado: (2016)

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022)

Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin.
por: Nelson, J., et al.
Publicado: (1989)

Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer
por: SHI, XUEFEI, et al.
Publicado: (2013)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021)

Somatostatin, Olfaction, and Neurodegeneration
por: Saiz-Sanchez, Daniel, et al.
Publicado: (2020)

Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells
por: El-Kouhen, Karim, et al.
Publicado: (2009)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells
por: Uehara, Takayuki, et al.
Publicado: (2014)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
por: Rossi, Valentina, et al.
Publicado: (2019)

Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
por: Liu, Wenjuan, et al.
Publicado: (2017)

Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review
por: Morland, David, et al.
Publicado: (2023)

Somatostatin in inflammatory bowel disease
por: Van Bergeijk, J. D., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_4qm2148d0f1h82ksg9p2s9pfiu